CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- 4 Open-market sale Senior Vice President sold 15,711 shares at an average $13.68 ($214,954)
- 4 Open-market sale Director sold 88,000 shares at an average $15.02 ($1,321,480)
- 4 Open-market sale Chief Financial Officer sold 7,990 shares at $10.98 ($87,730)
- 4 Open-market sale Director sold 70,000 shares at an average $14.02 ($981,700)
- 4 Open-market sale Chief Executive Officer sold 195,809 shares at $14.24 ($2,788,320)
- 4 Open-market sale Senior Vice President sold 34,308 shares at an average $11.60 ($397,953)
- 4 Open-market sale Director sold 350,000 shares at $11.70 ($4,095,000)
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 8-K Event Executive or director change
- 8-K Event Other events
- 4 Open-market sale Director sold 7,500 shares at $5.33 ($39,975)
- 8-K Event Shareholder vote results
- 8-K Event Other events
- S-3ASR Offering Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Shareholder vote results
Page 21 of 45 · 895 filings